FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

19338005: deux (valeur de l'attribut)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
33051000077117 deux fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
614921000077110 deux (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
deux est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
deux est un(e) (attribut) nombre true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
Thioridazine 2 mg/mL oral solution Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
Fluorescein sodium stain 2.5 mg/mL and proparacaine hydrochloride 5 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet Has presentation strength numerator value (attribute) False deux Inferred relationship Some 2
Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet Count of base of active ingredient False deux Inferred relationship Some
Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution Count of base of active ingredient False deux Inferred relationship Some
Memantine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Miconazole nitrate 2.5 mg/g and zinc oxide 150 mg/g cutaneous ointment Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Lidocaine hydrochloride 2 mg/mL solution for injection Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Clonazepam 2 mg orodispersible tablet Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
Epinephrine 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
Acetaminophen 21.7 mg/mL and hydrocodone bitartrate 500 microgram/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Acetaminophen 33.3 mg/mL and hydrocodone bitartrate 333 microgram/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/1 milliliter and guanethidine 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Epinephrine (as epinephrine bitartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Epinephrine (as epinephrine bitartrate) 5 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
Epinephrine 10 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely fluconazole 2 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Epinephrine 2 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Epinephrine 2 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely epinephrine 10 microgram/1 milliliter and mepivacaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Acetaminophen 650 mg and pentazocine 25 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Budesonide 160 microgram and formoterol 4.5 microgram/actuation powder for inhalation Count of base of active ingredient False deux Inferred relationship Some
Budesonide 80 microgram and formoterol 4.5 microgram/actuation powder for inhalation Count of base of active ingredient False deux Inferred relationship Some
Chlorpromazine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Epinephrine (as epinephrine bitartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely corbadrine 50 microgram/1 milliliter and mepivacaine hydrochloride 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely hydrocortisone 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Cocaine (as cocaine hydrochloride) 50 mg/mL and epinephrine 200 microgram/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet Count of base of active ingredient False deux Inferred relationship Some
Benserazide 12.5 mg and levodopa 50 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Neomycin and prednisolone only product in ocular dose form Count of base of active ingredient False deux Inferred relationship Some
Betamethasone and neomycin only product in otic dose form Count of base of active ingredient False deux Inferred relationship Some
Betamethasone and neomycin only product in nasal dose form Count of base of active ingredient False deux Inferred relationship Some
Hydrocortisone and neomycin only product in otic dose form Count of base of active ingredient False deux Inferred relationship Some
Product containing only hydrocortisone and neomycin in ocular dose form (medicinal product form) Count of base of active ingredient False deux Inferred relationship Some
Product containing only neomycin and prednisolone in otic dose form (medicinal product form) Count of base of active ingredient False deux Inferred relationship Some
Acetic acid and oxyquinoline only product in vaginal dose form Count of base of active ingredient False deux Inferred relationship Some
Acetic acid and oxyquinoline only product Count of base of active ingredient False deux Inferred relationship Some
Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch Count of base of active ingredient False deux Inferred relationship Some
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oral spray Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Count of base of active ingredient False deux Inferred relationship Some
Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial Count of base of active ingredient False deux Inferred relationship Some
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial Count of base of active ingredient False deux Inferred relationship Some
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial Count of base of active ingredient False deux Inferred relationship Some
Amoxicillin anhydrous (as amoxicillin) 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet Count of base of active ingredient False deux Inferred relationship Some
Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely epinephrine 1 microgram/1 milligram and lidocaine hydrochloride 100 microgram/1 milligram conventional release cutaneous patch (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial Count of base of active ingredient False deux Inferred relationship Some
Mezlocillin (as mezlocillin sodium) 2 g powder for solution for injection vial Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely coal tar 25 milligram/1 milliliter and lecithin 3 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution Count of base of active ingredient False deux Inferred relationship Some
Mequinol and tretinoin only product in cutaneous dose form Count of base of active ingredient False deux Inferred relationship Some
Product containing only aspirin and glycine in oromucosal dose form (medicinal product form) Count of base of active ingredient False deux Inferred relationship Some
Loteprednol and tobramycin only product in ocular dose form Count of base of active ingredient False deux Inferred relationship Some

Start Previous Page 13 of 24 Next End


This concept is not in any reference sets

Back to Start